Kraft P L, Skipper P L, Tannenbaum S R
Cancer Res. 1980 Aug;40(8 Pt 1):2740-2.
The pharmacokinetics and metabolism of N-nitrosomethyl-benzylamine, N-nitroso[methyl-14C]benzylamine, and N-nitrosomethyl[benzyl-7-14C]amine were studied in male Sprague-Dawley rats, and a major urinary metabolite was identified. N-Nitrosomethylbenzylamine (4.7 mg/kg body weight i.p.) was distributed throughout extracellular water and cleared from the whole blood by metabolism with a half-life of 66 min. Less than 1% of the administered dose of N-nitrosomethylbenzylamine (4.7 mg/kg i.p. or 3.3 mg/kg intragastric intubation) was excreted and expired as the parent compound. In the 24-hr period following injection of N-nitroso[methyl-14C1benzylamine (3.4 mg, 1 mCi/kg i.p.), 46% of the radioactivity administered was expired with a half-life of 2.1 hr. In contrast, 81% of the radioactivity from a dose of N-nitrosomethyl[benzyl-7-14C1amine (2.4 mg, 1 mCi/kg i.p.) was excreted in the urine with a half-life of 4.2 hr. Hippuric acid accounted for 80% of the radioactivity recovered in the urine.
对雄性Sprague-Dawley大鼠体内N-亚硝基甲基苄胺、N-亚硝基[甲基-¹⁴C]苄胺和N-亚硝基甲基[苄基-7-¹⁴C]胺的药代动力学和代谢进行了研究,并鉴定出一种主要的尿液代谢产物。N-亚硝基甲基苄胺(腹腔注射4.7mg/kg体重)分布于细胞外液,通过代谢从全血中清除,半衰期为66分钟。给予的N-亚硝基甲基苄胺剂量(腹腔注射4.7mg/kg或胃内插管3.3mg/kg)中,不到1%以母体化合物形式排泄和呼出。注射N-亚硝基[甲基-¹⁴C]苄胺(3.4mg,1mCi/kg腹腔注射)后的24小时内,给予的放射性物质中有46%以半衰期2.1小时呼出。相比之下,一剂N-亚硝基甲基[苄基-7-¹⁴C]胺(2.4mg,1mCi/kg腹腔注射)的81%放射性物质以半衰期4.2小时经尿液排泄。马尿酸占尿液中回收放射性物质的80%。